← Back to Search

Auditory-Cognitive Training for Hearing Loss (ARCog Trial)

N/A
Recruiting
Led By Diane M Brewer, MA
Research Sponsored by Gallaudet University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 3 months and 3 years post cochlear implant activation
60 years of age and over
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in amplitude and latency scores at 1-week post training. change from baseline at 2 months post training
Awards & highlights

ARCog Trial Summary

This trial will investigate whether an auditory brain training program can improve cochlear implant outcomes in older post-lingually deafened CI users. The study will evaluate the potential benefit of training on speech recognition performance, psychosocial and cognitive function.

Who is the study for?
This trial is for older individuals, aged 60 and above, who have had a cochlear implant activated between 3 months to 3 years ago. They must pass a cognitive test and have speech recognition scores within a specific range. People with single-sided deafness or non-fluent English speakers cannot participate.Check my eligibility
What is being tested?
The study tests if an auditory brain training program can help improve outcomes for older people with cochlear implants. It looks at how the training affects their ability to recognize speech, as well as their social and mental functions.See study design
What are the potential side effects?
Since this trial involves cognitive training programs rather than drugs or medical procedures, traditional side effects are not expected; however, participants may experience fatigue or frustration during the exercises.

ARCog Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cochlear implant was activated between 3 months and 3 years ago.
Select...
I am 60 years old or older.
Select...
I passed a test that checks for thinking problems.

ARCog Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline rhhi scores at 1-week post training. change from baseline rhhi scores at 2 months post training.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline rhhi scores at 1-week post training. change from baseline rhhi scores at 2 months post training. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
AZBio Sentence Test (Spahr A, Dorman M, Gilles,A et al (2012)
Client Orientated Scale of Improvement (COSI) Dillon H, James A , Ginis J, et al.(1997)
Cochlear Implant Quality of Life (CIQOL) McRacken,T (2019) McRackan T, Hand B; Velozo CA, Dubno J. (2019) Cochlear Implant Quality of Life (CIQOL)(CIQOL-10 Global). J Speech Lang Hear Res. 62(9
+5 more

ARCog Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Treatment: Auditory-Cognitive TrainingExperimental Treatment1 Intervention
Behavioral: AR Group will complete sessions in their home or office via internet. Sessions will include independent work using computer software two hours per week and one hour meeting with the clinician each week. One half of the training is devoted to auditory training and one half to auditory cognitive activities. Three assessment appointments are required. The goal is to evaluate the benefit of training on performance with cochlear implant.
Group II: Control: Non-auditory Cognitive TrainingPlacebo Group1 Intervention
Behavioral: The CT Group will complete two hours of training in their home or office via internet. Sessions will include independent work using computer software two hours per week. Training exercises will be chosen from: Ken-Ken, Sudoku, Crosswords, Word Search, Spot the Differences. Three assessment appointments are required. The goal is to evaluate the benefit of training on performance with cochlear implant.

Find a Location

Who is running the clinical trial?

Gallaudet UniversityLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Hearing Loss
20 Patients Enrolled for Hearing Loss
Department of Health and Human ServicesFED
224 Previous Clinical Trials
928,503 Total Patients Enrolled
Diane M Brewer, MAPrincipal InvestigatorGallaudet University
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Hearing Loss
20 Patients Enrolled for Hearing Loss

Media Library

Auditory-Cognitive Training Clinical Trial Eligibility Overview. Trial Name: NCT05176561 — N/A
Hearing Loss Research Study Groups: Treatment: Auditory-Cognitive Training, Control: Non-auditory Cognitive Training
Hearing Loss Clinical Trial 2023: Auditory-Cognitive Training Highlights & Side Effects. Trial Name: NCT05176561 — N/A
Auditory-Cognitive Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05176561 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for participants in this investigation?

"Yes, the clinical trial is open to recruitment. According to records on clinicaltrials.gov, this project was initially shared in May of 2022 and has been updated as recently as August 2nd of the same year."

Answered by AI

How many participants are actively engaging in this medical experiment?

"Yes, indeed. Data from clinicaltrials.gov confirms that recruitment for the trial is ongoing; it was initially posted on May 1st 2022 and most recently edited in August 2nd 2022. The study requires a total of 30 participants to be enrolled at one medical centre."

Answered by AI
Recent research and studies
~14 spots leftby Nov 2025